Literature DB >> 22819634

California pertussis epidemic, 2010.

Kathleen Winter1, Kathleen Harriman, Jennifer Zipprich, Robert Schechter, John Talarico, James Watt, Gilberto Chavez.   

Abstract

OBJECTIVE: In 2010, California experienced the highest number of pertussis cases in >60 years, with >9000 cases, 809 hospitalizations, and 10 deaths. This report provides a descriptive epidemiologic analysis of this epidemic and describes public health mitigation strategies that were used, including expanded pertussis vaccine recommendations. STUDY
DESIGN: Clinical and demographic information were evaluated for all pertussis cases with onset from January 1, 2010, through December 31, 2010, and reported to the California Department of Public Health.
RESULTS: Hispanic infants younger than 6 months had the highest disease rates; all deaths and most hospitalizations occurred in infants younger than 3 months. Most pediatric cases were vaccinated according to national recommendations, although 9% of those aged 6 months to 18 years were completely unvaccinated against pertussis. High disease rates also were observed in fully vaccinated preadolescents, especially 10-year-olds. Mitigation strategies included expanded tetanus, diphtheria, and acellular pertussis vaccine recommendations, public and provider education, distribution of free vaccine for postpartum women and contacts of infants, and clinical guidance on diagnosis and treatment of pertussis in young infants.
CONCLUSIONS: Infants too young to be fully vaccinated against pertussis remain at highest risk of severe disease and death. Data are needed to evaluate strategies offering direct protection of this vulnerable population, such as immunization of pregnant women and of newborns. The high rate of disease among preadolescents suggests waning of immunity from the diphtheria, tetanus, and acellular pertussis series; additional studies are warranted to evaluate the efficacy and duration of protection of the diphtheria, tetanus, and acellular pertussis series and the tetanus, diphtheria, and acellular pertussis series. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22819634     DOI: 10.1016/j.jpeds.2012.05.041

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  65 in total

Review 1.  What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

Authors:  Shelly Bolotin; Eric T Harvill; Natasha S Crowcroft
Journal:  Pathog Dis       Date:  2015-08-06       Impact factor: 3.166

Review 2.  The rise (and fall?) of parental vaccine hesitancy.

Authors:  Charitha Gowda; Amanda F Dempsey
Journal:  Hum Vaccin Immunother       Date:  2013-06-06       Impact factor: 3.452

3.  Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know.

Authors:  D MacDougall; B A Halperin; D MacKinnon-Cameron; L Li; S A McNeil; J M Langley; S A Halperin
Journal:  Hum Vaccin Immunother       Date:  2015-06-19       Impact factor: 3.452

4.  The History of Bordetella pertussis Genome Evolution Includes Structural Rearrangement.

Authors:  Michael R Weigand; Yanhui Peng; Vladimir Loparev; Dhwani Batra; Katherine E Bowden; Mark Burroughs; Pamela K Cassiday; Jamie K Davis; Taccara Johnson; Phalasy Juieng; Kristen Knipe; Marsenia H Mathis; Andrea M Pruitt; Lori Rowe; Mili Sheth; M Lucia Tondella; Margaret M Williams
Journal:  J Bacteriol       Date:  2017-03-28       Impact factor: 3.490

5.  Short-Read Whole-Genome Sequencing for Laboratory-Based Surveillance of Bordetella pertussis.

Authors:  Alex Marchand-Austin; Raymond S W Tsang; Jennifer L Guthrie; Jennifer H Ma; Gillian H Lim; Natasha S Crowcroft; Shelley L Deeks; David J Farrell; Frances B Jamieson
Journal:  J Clin Microbiol       Date:  2017-02-22       Impact factor: 5.948

6.  Strain variation and antigenic divergence among Bordetella pertussis circulating strains isolated from patients in Iran.

Authors:  Fatemah Sadeghpour Heravi; Vajihe Sadat Nikbin; Masomeh Nakhost Lotfi; Pouran Badiri; Nazanin Jannesar Ahmadi; Seyed Mohsen Zahraei; Fereshteh Shahcheraghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-09       Impact factor: 3.267

7.  Seroprevalence of pertussis in China: need to improve vaccination strategies.

Authors:  Yinghua Xu; Lichan Wang; Jin Xu; Xinjian Wang; Chen Wei; Peng Luo; Xiao Ma; Qiming Hou; Junzhi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-09-09       Impact factor: 3.452

8.  Maternal and neonatal vaccination protects newborn baboons from pertussis infection.

Authors:  Jason M Warfel; James F Papin; Roman F Wolf; Lindsey I Zimmerman; Tod J Merkel
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

Review 9.  Pertussis re-emergence in the post-vaccination era.

Authors:  Elena Chiappini; Alessia Stival; Luisa Galli; Maurizio de Martino
Journal:  BMC Infect Dis       Date:  2013-03-26       Impact factor: 3.090

Review 10.  Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis.

Authors:  Varun K Phadke; Robert A Bednarczyk; Daniel A Salmon; Saad B Omer
Journal:  JAMA       Date:  2016-03-15       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.